We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.41%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$67.1B
AUM Growth
-$1.4B
(-2%)
Cap. Flow
+$2.19B
Cap. Flow
% of AUM
3.26%
Top 10 Holdings %
Top 10 Hldgs %
22.03%
Holding
3,122
New
29
Increased
2,768
Reduced
217
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$146M |
| 2 |
Apple
AAPL
|
+$75.7M |
| 3 |
Tesla
TSLA
|
+$70.4M |
| 4 |
Amazon
AMZN
|
+$65M |
| 5 |
Procter & Gamble
PG
|
+$55.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$27.2M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$21.1M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$19.2M |
| 4 |
COHR
Coherent Inc
COHR
|
+$18.8M |
| 5 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.62% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTVE
2426
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $580K | ﹤0.01% |
66,405
+4,326
| +7% | +$44.9K |
|
|
ESPR
2427
DELISTED
Esperion Therapeutics
ESPR
| $574K | ﹤0.01% |
85,612
+9,899
| +13% | +$68K |
|
2428
IDT Corp
IDT
$1.62B
| $574K | ﹤0.01% |
23,122
+1,322
| +6% | +$34K |
|
|
CSTR
2429
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $572K | ﹤0.01% |
30,842
+1,630
| +6% | +$33K |
|
|
CTO
2430
CTO Realty Growth
CTO
$815M
| $570K | ﹤0.01% |
30,429
-51,933
| -63% | -$1.08M |
|
|
SWI
2431
DELISTED
SolarWinds Corporation Common Stock
SWI
| $569K | ﹤0.01% |
73,398
+3,922
| +6% | +$37.6K |
|
|
FORG
2432
DELISTED
ForgeRock, Inc.
FORG
| $568K | ﹤0.01% |
39,075
+4,705
| +14% | +$90.5K |
|
2433
Accel Entertainment
ACEL
$987M
| $566K | ﹤0.01% |
72,445
+3,421
| +5% | +$34.8K |
|
2434
Alto Ingredients
ALTO
$340M
| $566K | ﹤0.01% |
155,439
+13,311
| +9% | +$56K |
|
2435
Artesian Resources
ARTNA
$358M
| $565K | ﹤0.01% |
11,740
+1,384
| +13% | +$73.6K |
|
2436
Hyliion Holdings
HYLN
$690M
| $565K | ﹤0.01% |
196,736
+11,463
| +6% | +$41.8K |
|
2437
VSE Corp
VSEC
$6.12B
| $565K | ﹤0.01% |
15,971
+959
| +6% | +$37.3K |
|
|
INST
2438
DELISTED
Instructure Holdings, Inc.
INST
| $565K | ﹤0.01% |
25,337
+1,629
| +7% | +$38K |
|
2439
Seres Therapeutics
MCRB
$48.9M
| $564K | ﹤0.01% |
4,396
+473
| +12% | +$48.4K |
|
2440
Quanterix
QTRX
$190M
| $563K | ﹤0.01% |
51,089
+2,616
| +5% | +$33.3K |
|
2441
C4 Therapeutics
CCCC
$412M
| $562K | ﹤0.01% |
64,033
+3,981
| +7% | +$41.3K |
|
2442
FRP Holdings
FRPH
$421M
| $562K | ﹤0.01% |
20,684
+1,172
| +6% | +$34.2K |
|
2443
SmartFinancial
SMBK
$888M
| $560K | ﹤0.01% |
22,663
+1,274
| +6% | +$32.1K |
|
|
ZYXI
2444
DELISTED
Zynex
ZYXI
| $560K | ﹤0.01% |
61,719
+1,260
| +2% | +$11K |
|
2445
Merchants Bancorp
MBIN
$2.49B
| $557K | ﹤0.01% |
24,162
+1,387
| +6% | +$35.5K |
|
2446
Citizens & Northern Corp
CZNC
$455M
| $556K | ﹤0.01% |
22,988
+1,308
| +6% | +$31.9K |
|
2447
Luxfer Holdings
LXFR
$458M
| $556K | ﹤0.01% |
38,338
+2,428
| +7% | +$38.5K |
|
2448
LSB Industries
LXU
$693M
| $556K | ﹤0.01% |
39,020
+2,783
| +8% | +$39.4K |
|
2449
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $552K | ﹤0.01% |
42,983
+2,939
| +7% | +$33.5K |
|
|
EWCZ
2450
DELISTED
European Wax Center
EWCZ
| $551K | ﹤0.01% |
29,847
+5,701
| +24% | +$112K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, RhumbLine Advisers held 3,122 positions worth $67.1B, down 2% from $68.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2.19B of net new capital in Q3 2022, opening 29 new positions and adding to 2,768 existing holdings. Its largest new stake was Enhabit: 136,327 shares worth $1.91M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $21.1M trimmed.
- RhumbLine Advisers's largest Q3 2022 buy was Enhabit: 136,327 shares worth $1.91M.
- RhumbLine Advisers added most to Microsoft in Q3 2022, an estimated $146M increase.
- RhumbLine Advisers's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21.1M.
- RhumbLine Advisers fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $27.2M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $67.1B portfolio in Q3 2022.
- RhumbLine Advisers opened 29 new positions and closed 40 in Q3 2022.
- RhumbLine Advisers's portfolio value fell 2% quarter-over-quarter to $67.1B.
Based on RhumbLine Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.